(A) Immunoblot of total cell extract from 3T3 cells infected with retrovirus expressing either wild-type (p100) or a truncated form of human NFκB2 (p100ΔC, p100(1-753)) and serum-starved for 5 hours. Immunoblot was probed with an antibody to human NFκB2, which recognizes both p100 and p52. Amounts of p100 and p52 were quantitated and the mean (±SEM) p100/p52 ratio from 6 experiments is shown below each lane, demonstrating that p100ΔC is converted more efficiently to p52, than wild-type p100. RMCM mice. Amounts of proteins were determined from immunoblots such as those in (A), normalized to loading controls and then normalized to amounts in control B cells, which was set to 1. Analysis is from n=2 to 6 for each genotype. No significant differences were found. 
Supplemental Experimental Procedures Mice
Mice carrying a conditional allele of Syk (Syk tm1.1Nns , Syk fl ) with loxP sites in introns 10 and 11, flanking exon 11, and mice with an insertion of a cDNA encoding the MerCreMer fusion protein (Zhang et al., 1996) into the ROSA26 locus, (Gt(ROSA)26Sor tm1(cre/Esr1*)Nns , Rosa26
MerCreMer , RMCM) will be described elsewhere (S. McCleary and N. Smithers, manuscript in preparation). Mice containing a cDNA for CreER T2 (Feil et al., 1997) (Fang et al., 1996) , C57BL/6JNimr-Rag1 tm1Mom (Mombaerts et al., 1992) . B6.SJL mice were obtained from the breeding facility at NIMR. This study was conducted following authorization by the UK Home Office, under relevant Project Licence authority.
Tamoxifen and BrdU Treatment of Mice
Mice were injected intraperitoneally for 5 days with 2 mg/day of tamoxifen (Sigma) resuspended at 20 mg/ml in corn oil (Sigma). For some studies, 14 days after start of tamoxifen treatment, Syk fl/+ RMCM and Syk fl/-RMCM mice were injected intraperitoneally with 1 mg BrdU (Sigma), and then kept on drinking water with 1 mg/ml BrdU for 7 days.
Bone Marrow Chimeras
Bone marrow was harvested from femora and tibiae of donor mice, resuspended in ACK lysis buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 100 μM EDTA) for 2 min at room temperature to lyse red blood cells, and then injected into recipient mice (at least 1x10 6 cells/recipient). Recipient Rag1-deficient animals were irradiated with 5Gy using a 
Retroviral Vectors
pMIGR1 (Pear et al., 1998) and pMIGR1_hu-p100 plasmids were a kind gift from M. Cancro; pMSCV_huCD2 (Clohessy et al., 2004) vector was a gift from Owen Williams (UCL). pMIGR1_hu-p100ΔC was generated by truncating hu-p100 at amino acid 753. pMIGR1_Syk was constructed by inserting an EcoRI-MfeI fragment containing the entire mouse Syk coding sequence including 54 and 66 bases of 5' and 3'UTR, respectively, into the EcoRI site of pMIGR1. Site directed mutagenesis (Quickchange II-E, Stratagene) was used to generate the kinase-inactive Syk mutant (K396R). pMSCV_BAFFR_huCD2 plasmid was generated by inserting a 971 bp EcoRI fragment from IMAGE clone 40044559 into the EcoRI cloning site of pMSCV_huCD2. pMSCV_caMEK1_huCD2 carries the constitutively active form of human MEK1 (E218, E222) (Cowley et al., 1994) and was a kind gift from Chris Marshall.
Generation of Retroviruses
Transfection mixture of 15µg retroviral vector DNA, 45 µl Genejuice (Merck 70967) and 800µl FCS-free DMEM medium was incubated at room temperature for 45 min before being added dropwise to Plat-E packaging cells (Morita et al., 2000) (2x10 6 in a 10cm plate). Supernatant containing retrovirus was harvested 48, 72 and 96 hours after transfection, and concentrated by centrifugation at 15,000g. Titers of supernatants were determined by infecting NIH-3T3 cells.
Retroviral Chimeras Syk
RMCM mice were injected intraperitoneally with 100 mg/kg 5-fluorouracil (Invivogen). Five days later bone marrow was harvested, treated with ACK lysis buffer, then cultured overnight in DMEM-plus medium (DMEM with 10% FCS (Lonza), 100U/ml Penicillin, 100µg/ml Streptomycin, 100µM non-essential amino acids, 20mM HEPES buffer and 100µM 2-mercaptoethanol) containing 100ng/ml rmSCF (Peprotech), 6 ng/ml IL-3 (Sigma) and 10 ng/ml rmIL-6 (Peprotech). 24 hours later cells were moved onto Retronectin-coated plates (Takara Clontech T100B), viral supernatant was added and cultured overnight. This infection step was repeated two more times on consecutive days before cells were harvested and injected intravenously (at least 2.5x10 5 cells/recipient) into B6.SJL recipient mice that had received 2 doses of 4.75Gy irradiation 3 hours apart. Six weeks after cell transplantation the efficiency of infection was assessed by flow cytometry of peripheral blood, and tamoxifen treatment was started.
Flow Cytometry
Single cell suspensions of bone marrow, spleen, blood or peritoneal wash were treated with ACK lysis buffer to remove red blood cells before staining in FACS buffer (PBS, 0.5% BSA, 0.01%NaN 3 , pH 7.2-7.4) containing the appropriate, pre-titered antibodies. Antibodies used, indicating antigen and fluorophore (and clone): CD1d-PE and CD1d-bio (clone 1B1), CD21-FITC (eBio8D9), CD23-PE (B3B4), B220-eFluor450 (RA3-6B2), CD93-APC (AA4.1), IgM-PECy7 (II/41), IgD-FITC and IgD-bio (11-26), Ly5.1-APC (A20), Ly-5.2-FITC (104), bio-CD43 (eBioR2/60), BAFFR-APC (eBio-7H22-E16) were from eBiosciences, CD4-PerCP (RM4-5) and CD8-PerCP (53-6.7) from BioLegend, CD2-PE (RM2-5), CD9-bio (KMC8), CD21-PE (7G6), CD69-FITC (H1.2F3), CD86-PE (GL-1), huCD2-PE (RPA-2.10), Sreptavidin-PerCP (554064) from Becton Dickinson, CD19-APC (RM705) and CD23-APC (MCD2305) from Life Technologies, goat-antimouse IgM Fab-FITC (115-097-020) from Jackson Immunoresearch, goat-anti-mouse IgM-FITC (STAR86F) from Serotec and biotinylated goat-anti-mouse-IgM from Southern Biotech. Intracellular antigens were detected by fixing the cells for 30 min at room temperature with 3% PFA, followed by treatment for 10 min with 50 mM NH 4 Cl and permeabilization with 1% NP-40 (Sigma) before adding antibodies or 1µg/ml DAPI (Sigma). BrdU incorporation was detected by intracellular staining with BD Fastimmune anti-BrdU-FITC with DNAse (Becton Dickinson #340649).
B Cell Survival Assay
Splenic B cells were purified by Dynabead depletion, using biotinylated anti-CD43 and anti-CD1d antibodies and Streptavidin-coupled Dynabeads (Life Technologies). Purity of the resulting B cell preparation was assessed by flow cytometry. B cells (10 6 /ml) were cultured in DMEM-plus medium with or without 200 ng/ml BAFF (Peprotech). In some cases the SFK inhibitors PP1, PP2 or Src-I were added. Cells were harvested 1 -4 days later, stained with antibodies to a B cell marker (B220 or CD19), anti-IgM and antihuCD2 (if required), resuspended in FACS buffer containing PerCP-beads (Becton Dickinson, #340497) and, just before analysis, TO-PRO-3 (Life Technologies) was added to mark dead or dying cells. Number of live B cells per 10,000 beads was determined, and then corrected using the purity data from the input samples. Values were normalized either to Syk fl/+ RMCM B cells cultured in the presence of BAFF or to the number of input B cells.
Immunoblotting
To purify B cells, splenocyte suspensions were treated with ACK lysis buffer, incubated with biotinylated anti-CD43 and anti-CD1d, and then with Streptavidin Dynabeads and labeled cells were removed with a magnet. For the preparation of BCR-deficient B cells, biotinylated anti-IgM and anti-IgD antibodies were also included in the depletion mix. Depleted cells were washed, resuspended in fresh medium, and after at least 5 min at 37°C, BAFF (200 ng/ml) or anti-IgM F(ab')2 (10 µg/ml, Jackson ImmunoResearch) was added for the time indicated. In some cases cells were pre-incubated with PP1 (50μM) for 30 min. Cell lysates were prepared using RIPA buffer. After removal of cell debris by centrifugation, proteins of cell lysates were separated on 10% or 12.5% SDS-PAGE gels and transferred onto Immobilon-FL PVDF membrane (Millipore) by standard techniques. Membranes were blocked for 1 hour in Odyssey Blocking Buffer (Li-Cor #927-40000), and then probed with the following antibodies: anti-phospho-Igα (Y182) rabbit polyclonal, Cell Signaling #5173S; anti-phospho-Syk/ZAP (Y352/Y319) rabbit polyclonal, Cell Signaling #2701L; anti-phospho-Erk1/2 mouse monoclonal, Santa Cruz sc-7383; anti-Erk2 rabbit polyclonal, Santa Cruz sc-154; anti-Syk mouse monoclonal (clone 5F5), Biolegend 646002; anti-NFκB2 (p100/p52) rabbit polyclonal, Cell Signaling #4882; anti-Igα mouse monoclonal (clone 24C2.5), eBioscience #14-0791-82; antiphospho-Akt (S473) rabbit polyclonal, Cell Signaling, #9271L; anti-Akt mouse monoclonal (B1), Santa Cruz sc-5298; anti-Bcl-2 rabbit monoclonal, clone 50E3, Cell Signaling #28705; anti-Bcl-xL rabbit polyclonal, Santa Cruz sc-634; anti-Bad rabbit polyclonal, Cell Signaling #9292; anti-Bim rabbit polyclonal, Assay Designs #AAP-330; anti-Mcl1 rabbit polyclonal, Rockland #600-401-394; anti-Bok rabbit polyclonal, Cell Signaling #4521; anti-Puma rabbit polyclonal, Cell Signaling #4976; anti-Bax rabbit polyclonal, Cell Signaling #2772; anti-active Bax mouse monoclonal (clone 6A7), Santa high cells were isolated from Sykdeficient spleens to ensure that all sorted cells have deleted the conditional Syk allele. RNA was isolated using RNEasy mini kit (Qiagen). Two control and two Syk-deficient libraries were made from 1 µg total RNA each using an mRNA-Seq 8-Sample Prep Kit (Illumina). Samples were analyzed with an Illumina Genome analyzer II, collecting 40 million reads of 35 bases per sample. CLC Genomics Workbench (CLC bio) was used to map the reads to a reference sequence (NCBI37/mm9) and to generate expression values (RPKM).
For microarray analysis, splenic B cells were sorted as described above (n=5 of each genotype), and RNA was isolated using Trizol, then further purified using the RNEasy kit. RNA was labeled, hybridized to Affymetrix Mouse Gene 1.0 ST chips and scanned by UCL Genomics. Data were analyzed using Genespring (Agilent Technologies) for significant changes in gene expression between mutant and control samples using the t test, and resulting p-values were corrected for multiple testing using the Benjamini-Hochberg method.
Statistical Analysis
All statistical comparisons were carried out using the nonparametric two-tailed MannWhitney test. Statistically significant differences are indicated on the Figures: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
